CIRT leads to temporary urinary function decline, normalizing within three months and stable for five years. Prostate volume decreases significantly without ADT, remaining reduced for five years. T ...

Johnson & Johnson’s PROTEUS Phase 3 trial shows apalutamide + hormone therapy before/after surgery improves outcomes in ...

Developing a manual clinical trials screening process in a diverse southern gynecologic oncology practice in the Deep South. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This ...

Beyond the physical, a prostate cancer diagnosis carries significant emotional weight. Understanding this spectrum of ...

Results of a multicenter clinical trial found that adding the investigational adenoviral-based viral immunotherapy ...

The prostate is a small gland located in the male reproductive system that's essential for producing seminal fluid. When it's healthy, the prostate is shaped similarly to a walnut, but prostate cancer ...

Four synthesized findings illustrate the nuanced experience of men undergoing ADT: symptom production, symptom perception, symptom meaning, and symptom response. Men undergoing androgen deprivation ...

Ceramides-lipid molecules in cells that affect many physiological functions including cell differentiation, migration, and ...

A radiation oncology nurse explains the spectrum of side effects that can come with radiation for prostate cancer. For patients with prostate cancer undergoing radiation, the side effect burden exists ...

A 68-year-old man presented to the emergency department with haematuria and penile pain. His medical history included benign prostatic hyperplasia, but no follow-up examinations had been performed.

(NYSE: PFE) today announced detailed results from the pivotal Phase 3 TALAPRO-3 study of TALZENNA ® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI ® ...

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, researchers are using the same tactics to advance prostate cancer treatment. A recent ...